Skip to main content

Congenital Afibrinogenemia

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Grifols
GrifolsNEW YORK, NY
2 programs
Human Plasma-Derived Fibrinogen ConcentratePHASE_1_21 trial
FIB GrifolsPHASE_31 trial
Active Trials
NCT02281500Completed24Est. Nov 2019
NCT04636268Withdrawn0Est. Mar 2025
Biotest Pharmaceuticals
Biotest PharmaceuticalsGermany - Dreieich
1 program
BT524PHASE_31 trial
Active Trials
NCT02065882Completed67Est. Nov 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GrifolsFIB Grifols
Biotest PharmaceuticalsBT524
GrifolsHuman Plasma-Derived Fibrinogen Concentrate

Clinical Trials (3)

Total enrollment: 91 patients across 3 trials

FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis

Start: Dec 2023Est. completion: Mar 20250
Phase 3Withdrawn

Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency

Start: Mar 2013Est. completion: Nov 202067 patients
Phase 3Completed
NCT02281500GrifolsHuman Plasma-Derived Fibrinogen Concentrate

Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia

Start: Jul 2016Est. completion: Nov 201924 patients
Phase 1/2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.